Find clinical trials for Diabetes in Portland, OR
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Diabetes trials near Portland, OR, USA:
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Portland, Oregon, United States and 17 other locations
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Portland, Oregon, United States and 42 other locations
This study will look at the effects of CagriSema in people with both type 2 diabetes and painful diabetic peripheral neuropathy, co...
Phase 2
Portland, Oregon, United States and 43 other locations
Study GR41675 is a Multicenter, Randomized Study in Participants with Diabetic Retinopathy (DR) Without Center-Involved Diabetic Ma...
Phase 3
Portland, Oregon, United States and 75 other locations
weight in adult participants with obesity or overweight and type 2 diabetes. The study will last about 77 weeks and may include up to 22 vis...
Phase 3
Portland, Oregon, United States and 138 other locations
This study will look at how much CagriSema helps participants with type 2 diabetes lower their blood sugar and body weight. CagriSema is a n...
Phase 3
Portland, Oregon, United States and 48 other locations
decrease in the kidneys' ability to work properly, and type 1 diabetes.In people with type 1 diabetes, the body does not make enoug...
Phase 3
Portland, Oregon, United States and 86 other locations
fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community ...
Phase 3
Portland, Oregon, United States and 60 other locations
This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high ...
Phase 2
Portland, Oregon, United States and 26 other locations
The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes...
Phase 3
Portland, Oregon, United States of America and 392 other locations
Clinical trials
Research sites
Resources
Legal